OTC Markets OTCQB - Delayed Quote
USD
CERo Therapeutics Holdings, Inc. (CERO)
0.0310
-0.0010
(-3.03%)
As of 9:30:05 AM EDT. Market Open.
Loading chart for CERO
- Previous Close
0.0320 - Open
0.0310 - Bid 0.0300 x 2000000
- Ask 0.0320 x 2000000
- Day's Range
0.0310 - 0.0310 - 52 Week Range
0.0300 - 28.4000 - Volume
102 - Avg. Volume
480,196 - Market Cap (intraday)
654,182 - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
-- - EPS (TTM)
-2.1400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
www.cero.bioRecent News: CERO
View MorePerformance Overview: CERO
Trailing total returns as of 4/14/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
CERO
53.73%
S&P 500 (^GSPC)
1.11%
1-Year Return
CERO
99.77%
S&P 500 (^GSPC)
28.03%
3-Year Return
CERO
100.00%
S&P 500 (^GSPC)
67.28%
5-Year Return
CERO
100.00%
S&P 500 (^GSPC)
67.80%
Earnings Trends: CERO
View MoreAnalyst Insights: CERO
View MoreStatistics: CERO
View MoreValuation Measures
As of 4/13/2026
-
Market Cap
675.28k
-
Enterprise Value
8.28M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
--
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-210.22%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-49.76M
-
Diluted EPS (ttm)
-2.1400
Balance Sheet and Cash Flow
-
Total Cash (mrq)
1.95M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-7.85M
Compare To: CERO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights: CERO
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
